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The use of synthetic non-coding RNAs for post-transcriptional regulation of gene expression
has not only become a standard laboratory tool for gene functional studies but it has also
opened up new perspectives in the design of new and potentially promising therapeutic
strategies. Bioinformatics has provided researchers with a variety of tools for the design,
the analysis, and the evaluation of RNAi agents such as small-interfering RNA (siRNA),
short-hairpin RNA (shRNA), artificial microRNA (a-miR), and microRNA sponges. More
recently, a new system for genome engineering based on the bacterial CRISPR-Cas9 sys-
tem (Clustered Regularly Interspaced Short Palindromic Repeats), was shown to have the
potential to also regulate gene expression at both transcriptional and post-transcriptional
level in a more specific way. In this mini review, we present RNAi and CRISPRi design
principles and discuss the advantages and limitations of the current design approaches.
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INTRODUCTION
Natural regulatory RNAs are a heterogenous group of endogenous
non-coding RNAs that modulate biological processes at many lev-
els through different mechanisms. They have inspired the design
of synthetic RNA molecules, such as riboswitches, sensors, and
controllers, as key elements for programing cellular behaviors, as
well as antisense-based approaches for specific gene expression
regulation, which is the focus of this mini-review (Sharma et al.,
2008; Culler et al., 2010; Liang et al., 2011).
RNA interference (RNAi) was discovered in 1998, when Andrew
Fire and Craig C. Mello reported the capability of exogenous
double-stranded RNAs (dsRNA) to silence genes in a specific man-
ner in C. elegans (Fire et al., 1998). Central molecules in RNAi are
microRNA (miRNA) and small-interfering RNA (siRNA).
miRNAs are small endogenous non-coding RNAs, typically 18–
22 bp long, which derive from longer hairpin-shaped precursors
called pre-miRNA (Bartel, 2004). A pre-miRNA can encode one
or two different mature miRNAs, one from each arm (-5p and
-3p). Pre-miRNAs come, in turn, from primary transcripts, called
pri-miRNA, which are transcribed from miRNA genes. Mature
miRNAs are incorporated into effector protein complexes called
RISCs (RNA-induced silencing complex) and exert their regula-
tory function by binding specific target mRNAs through perfect
or, more often, partial sequence complementarity, leading to the
inhibition of their translation or promoting their degradation.
siRNAs are mostly exogenous dsRNA molecules derived from
viral RNAs or artificially introduced into the cell (Chu and Rana,
2007).
The use of artificially designed siRNA has become a common
and powerful strategy for the knock-down of gene expression
yielding functional including therapeutic phenotypes (Gunsalus
and Piano, 2005; Kim and Rossi, 2007). Several optimizations have
been proposed in order to improve their efficacy and specificity
(Liu et al., 2012b). Although research is focused on the develop-
ment of selective delivery systems, a crucial factor is the presence
of undesired off-target effects. siRNAs are designed to be perfectly
complementary to their target sequences, ideally with few or no
off-target genes. However, several studies have shown that a siRNA
can bind mRNAs through partial complementarity, in a miRNA-
like way, thus leading to undesirable and not easily predictable
side effects (Birmingham et al., 2006; Jackson et al., 2006). In fact,
despite the advances made in the recent past years, miRNA-target
recognition has revealed itself to be a very dynamic mechanism
influenced by many factors, which are only partially understood
(Bartel, 2009; Thomas et al., 2010).
Along with specific gene silencing, the artificial repression of
miRNAs can also provide a valuable tool for functional studies
and have important therapeutic applications (Esquela-Kerscher
and Slack, 2006; Garofalo et al., 2008; Croce, 2009). Two different
strategies have been developed for the specific inhibition of miR-
NAs: antagomiRs and miRNA sponges (Krützfeldt et al., 2005;
Ebert et al., 2007). The former consist of small RNAs exhibit-
ing anti-complementarity to the miRNA to repress. The latter
are longer RNA transcripts that act as attractors for miRNAs by
distracting them from their original targets.
Finally, a novel methodology for artificial gene expression and
miRNA regulation based on Clustered Regularly Interspaced Short
Palindromic Repeats (CRISPR) has been recently proposed (Qi
et al., 2013). CRISPR interference (CRISPRi) employs an engi-
neered CRISPR/Cas system to control gene expression at the
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transcriptional level through a catalytically inactive Cas9 protein.
Recent studies have shown that the CRISPR/Cas system can also
target RNA (Hale et al., 2009).
In this mini-review, we summarize RNAi and CRISPRi design
principles and discuss the advantages and limitations of the
current approaches.
siRNA DESIGN PRINCIPLES
siRNA are usually synthesized as double-stranded RNA duplexes
or as hairpin-shaped molecules called shRNA. The siRNA design
process consists of the identification of a functional binding site
on a target mRNA sequence, which will correspond to the sense
strand of the siRNA. The anti-sense sequence is obtained as the
complement to the sense strand.
Many studies have been conducted to determine the features
associated to functional siRNAs and have allowed to establish
siRNA design rules. Elbashir et al. (2001b) suggest to choose
the 23-nt sequence motif AA(N19)TT as binding site, where N19
means any combination of 19 nucleotides (nt) and corresponds
to the sense strand of the siRNA. The complement to AA(N19)
corresponds to the anti-sense strand (Figures 1A–C).
Symmetric 3′ dTdT overhangs are added to the siRNA duplex
to improve its stability and facilitate RISC loading. Although other
combinations of nucleotides are acceptable, dGdG overhangs
should be avoided, as they appear to be associated to decreased
siRNA activity (Elbashir et al., 2001a,b; Strapps et al., 2010). siRNA
duplexes often have asymmetric loading of the anti-sense versus
sense strands. The strand whose 5′ end is thermodynamically less
stable is preferentially incorporated into the RISC (Khvorova et al.,
2003).
siRNA design rules can be classified into sequence and struc-
ture rules (See Table S1 in Supplementary Material). Sequence
rules concern the position of the binding site in the target
transcript and its nucleotide composition. The target region
should be chosen preferably 50-100 nt downstream of the start
codon and should avoid the middle of the coding sequence
(Elbashir et al., 2001a; Hsieh et al., 2004). The G/C content of
the binding site, and consequently of the siRNA, is relevant to
the silencing activity and should be in the range of 30–55%,
although values as low as 25% or as high as 79% are still asso-
ciated to functional siRNAs (Reynolds et al., 2004; Liu et al.,
2012a).
FIGURE 1 | Artificial RNA constructs for miRNA and gene regulation.
(A) Standard double strand siRNA; the anti-sense strand is the active
agent which binds the target site. (B) shRNA construct; it is produced
inside the target cell from a DNA construct that has been delivered to the
nucleus and it expresses the anti-sense active strand. (C) The siRNA
anti-sense strand binds the target mRNA with perfect complementarity.
(D) Example of an a-miR sequence targeting two different sites with
partial complementarity. The seed sequence of the a-miR, highlighted in
bold characters, matches perfectly the target sites. (E) The antagomiR
sequence (orange) perfectly matches the sequence of the target miRNA
(black). (F) The Tiny LNA sequence (orange) perfectly matches the seed
sequence of the target miRNA (black). (G) miRNA sponge construct with
four miRNA binding sites separated by spacers. (H) Synthetic TUD
construct with two exposed miRNA binding sites. (I) Model of a CRISPR
sgRNA sequence binding the target DNA region. The PAM sequence
(blue) is a short DNA motif juxtaposed to the DNA complementary region.
The base-pairing nucleotides of the sgRNA are shown in red, while the
dCas9-binding hairpin is in green.
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Table 1 | Computational tools for siRNA, a-miR and CRISPR design.
Tool URL Reference
siRNA DesignTools
OptiRNAi 2.0 http://rnai.nci.nih.gov Cui et al. (2004)
siDirect 2 http://sidirect2.rnai.jp Naito et al. (2009)
siRNA Scales http://gesteland.genetics.utah.edu/siRNA_scales Matveeva et al. (2007)
siExplorer http://rna.chem.t.u-tokyo.ac.jp/cgi/siexplorer.htm Katoh and Suzuki (2007)
RFRCDB-siRNA http://www.bioinf.seu.edu.cn/siRNA/index.htm Jiang et al. (2007)
OligoWalk http://rna.urmc.rochester.edu/cgi-bin/server_exe/oligowalk/oligowalk_form.cgi Lu and Mathews (2008)
Sfold http://sfold.wadsworth.org Ding et al. (2004)
siMAX http://www.operon.com/products/siRNA/sirna-overview.aspx Schramm and Ramey (2005)
DSIR http://biodev.cea.fr/DSIR/ Vert et al. (2006)
siRNA Scan http://bioinfo2.noble.org/RNAiScan.htm Xu et al. (2006)
RNAxs http://rna.tbi.univie.ac.at/cgi-bin/RNAxs Tafer et al. (2008)
i-Score http://www.med.nagoya-u.ac.jp/neurogenetics/i_Score/i_score.html Ichihara et al. (2007)
siVirus http://sivirus.rnai.jp Naito et al. (2006)
a-miR DesignTools
miR-Synth http://microrna.osumc.edu/mir-synth/ Lagana et al. (2014)
CRISPR DesignTools
Cas9 Design http://cas9.cbi.pku.edu.cn Ma et al. (2013)
CRISPR Design http://crispr.mit.edu Hsu et al. (2013)
Broad Inst. sgRNA Designer http://www.broadinstitute.org/rnai/public/analysis-tools/sgrna-design Doench et al. (2014)
sgRNAcas9 http://www.biootools.com Xie et al. (2014)
CRISPR Genome Analyzer http://crispr-ga.net Guell et al. (2014)
CasOT http://eendb.zfgenetics.org/casot Xiao et al. (2014)
DNA 2.0 gRNA Design Tool https://www.dna20.com/eCommerce/cas9/input Cong et al. (2013); Ran et al. (2013)
E-CRISP http://www.e-crisp.org/E-CRISP/ Heigwer et al. (2014)
ZiFiT http://zifit.partners.org/ZiFiT/ Hwang et al. (2013)
CHOPCHOP https://chopchop.rc.fas.harvard.edu Montague et al. (2014)
CRISPRseek http://www.bioconductor.org/packages/release/bioc/html/CRISPRseek.html Zhu et al. (2014)
SSFinder https://code.google.com/p/ssfinder/ Upadhyay and Sharma (2014)
URLs and references are given for each tool.
Numerous sequence rules regard the selection of nucleotides
to prefer or avoid in specific positions of either the sense or the
anti-sense strand of the duplex. For example, a higher content of
A/U nucleotides in the 5′ end of the anti-sense strand of the siRNA
yields higher silencing efficacy (Ui-Tei et al., 2004; Shabalina et al.,
2006). Also, the 5′ half of the anti-sense strand dictates compe-
tition potency of siRNAs, which is a consequence of the RNAi
machinery saturation followed by transfection of multiple siRNAs
(Yoo et al., 2008).
Other relevant sequence features include the absence of inter-
nal repeats and the presence/absence of specific motifs (Reynolds
et al., 2004).
Structure rules refer to the thermodynamics features of the
siRNA/target duplex and are mostly expressed in terms of the
nucleotide composition of the duplex itself or of the area sur-
rounding the binding site (Chalk et al., 2004; Shabalina et al.,
2006). Structure rules specify functional levels of binding energy
at different positions of the duplex, and optimal energy difference
between different positions of the duplex itself. Another impor-
tant thermodynamic feature associated to siRNA efficacy is the
structural accessibility of the target site. It has been demonstrated,
in fact, that an mRNA stretch, which is not involved in a strict sec-
ondary structure exhibits a stronger binding affinity to a siRNA (or
miRNA) molecule than one with a highly structured conformation
(Tafer et al., 2008).
Several optimizations have been proposed to improve the activ-
ity of siRNA molecules, such as a more accurate prediction of the
active strand of the duplex, design rules to avoid competition with
endogenous miRNAs and vectors expressing multiple siRNAs at
once (Cheng et al., 2009; Ma et al., 2014; Malefyt et al., 2014).
Many tools are available online for the design of siRNA and
shRNA molecules (see Table 1).
OFF-TARGETS, MULTIPLE TARGETS, AND THE a-miR
APPROACH
Although siRNAs and shRNAs are designed to specifically tar-
get a single gene through perfect complementarity to the binding
site, several studies show that they can partially bind to many
other transcripts in a way reminiscent of the endogenous miRNAs
(Birmingham et al., 2006; Jackson et al., 2006). A single miRNA can
potentially regulate hundreds of different mRNAs through partial
sequence complementarity. In particular, perfect base pairing of
www.frontiersin.org December 2014 | Volume 2 | Article 65 | 3
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Laganà et al. Synthetic RNAs for gene regulation
the 5′ end region of the miRNA, termed “seed,” to a binding site
located in the 3′ UTR of a mRNA, is usually sufficient to yield a
significant repression of the target, while other recent studies also
report functional centered site-mediated interactions (Shin et al.,
2010; Helwak et al., 2013; Martin et al., 2014).
This represents a relevant drawback of single-target siRNAs,
especially when pools of four or five siRNA duplexes per target
gene are used to achieve stronger repression but also leading to
widespread off-target effects.
One approach to the off-targeting problem consists of employ-
ing pools of siRNAs, at low concentrations, that target a single
gene in multiple sites (Straka and Boese, 2010). The advantage of
this approach lies in the fact that such pools are both effective on
that one target, while the effects of a low concentrations siRNA
on other potential targets should be negligible (Arvey et al., 2010;
Larsson et al., 2010). Another study showed that siRNAs with a
bulge at position 2 of the anti-sense strand were able to discrim-
inate better between perfectly matched and mismatched targets
(Dua et al., 2009; Li et al., 2010).
Targeting multiple genes can also be an intended choice, as
there are many biological and biomedical applications in which
it is important to regulate multiple genes at once while suffering
as few side effects as possible. One way to achieve this goal is to
exploit the multi-targeting properties of endogenous miRNAs by
employing artificially designed miRNAs, or a-miRs. Two recent
papers have shown that a-miRs can successfully repress at least
two targets simultaneously by binding to one or more sites in their
3′ UTRs (Figure 1D) (Arroyo et al., 2014; Lagana et al., 2014). The
employment of a single multi-target a-miR in place of a pair or a
pool of single-target siRNAs is likely to yield significant repression
of targets with few off-target effects.
SILENCING THE SILENCERS: ANTAGOMIRS AND miRNA
SPONGES
While the inhibition of over-expressed genes has been the main
goal of RNAi research for years, the de-repression of down-
regulated miRNA targets has increasingly gained importance
over time. The inhibition of endogenous miRNAs was first
introduced in 2005 by Krützfeldt et al. (2005). They employed
cholesterol-conjugated oligo-ribonucleotides, which they termed
“antagomiRs,” reproducing the anti-sense strand of the endoge-
nous miRNA they inhibit. Their design is thus straightforward, as
there is not much space for sequence variations (Figure 1E). Since
then, a variety of chemical modifications have been proposed in
order to increase binding affinity, improve nuclease resistance and
facilitate in vivo delivery. They include locked nucleic acid (LNA),
which possesses the highest affinity toward complementary RNA,
Bifunctional oligodeoxynucleotide/antagomiR constructs, which
ensure high transfection efficiency and prevention of unintended
immune stimulation, and morpholino oligomers, which have been
shown to be efficient inhibitors of both pri-miRNA and mature
miRNA activity in zebrafish and Xenopus laevis (Summerton and
Weller, 1997; Braasch and Corey, 2001; Petersen and Wengel, 2003;
Ziegler et al., 2013). A further variant of antagomiRs is represented
by short seed-targeting LNA oligonucleotides, called tiny LNAs.
These molecules allow simultaneous inhibition of miRNAs within
families sharing the same seed (Figure 1F) (Obad et al., 2011).
AntagomiRs represent one well-established tool for miRNA
functional studies, and several works have also shown successful
employment of antagomiRs as therapeutic agents able to restore
disease-associated pathways altered by miRNA up-regulation. Like
siRNAs, AntagomiRs can also have significant off-target effects,
as they act like endogenous miRNAs and may hit complemen-
tary mRNA transcripts. However, experiments have showed no
detectable effect on mRNAs with perfect tiny LNA complementary
sites, not even at the proteomic level (Obad et al., 2011).
miRNA sponges are an alternative to antagomiRs. They act
as competitive inhibitors that distract endogenous miRNAs from
their natural targets. Many sponge variants have been described,
such as miRNA-target mimics, miRNA decoys, and miRNA
erasers, and they all consist of RNA constructs containing multi-
ple binding sites for the miRNA to be sponged (Figure 1G) (Carè
et al., 2007; Ebert et al., 2007; Franco-Zorrilla et al., 2007; Sayed
et al., 2008).
A basic sponge consists of an RNA sequence exhibiting 4–10
miRNA binding sites separated by short spacers, usually 2–4 nt
long. These sites can be either bulged or perfectly complementary
to the miRNAs. In the first case, a bulge at positions 9–12 of the
binding site is introduced in order to prevent cleavage and degra-
dation of the sponge. Sponges with bulged binding sites produce
stronger de-repressive effects than sponges with perfect binding
sites (Ebert et al., 2007). Kluiver et al. (2012) developed a method-
ology for the rapid generation of miRNA sponges by making use of
simple constructs with up to 20 perfect or bulged miRNA binding
sites.
Structural optimizations have also been proposed. TuD RNAs
(tough decoy RNAs) are efficient sponges with structurally accessi-
ble and indigestible miRNA binding sites (Figure 1H) (Haraguchi
et al., 2009, 2012). The optimal TuD RNA consists of a bulged
stem-loop structure where both sides of the bulge are miRNA
binding sites which are perfectly complementary to the miRNA
sequence and which do not form any base-pairing regions longer
than 9nt.
CRISPRi: THE GENE SILENCING REVOLUTION
An exciting and promising advance in the field of artificial gene
regulation comes from Clustered Regularly Interspaced Short
Palindromic Repeats (CRISPR). CRISPR is a natural adaptive
immune system used by archaea and bacteria against phage and
plasmids (Jinek et al., 2012). This system is genomically encoded
by the prokaryotic chromosome and consists of a series of short
repeats separated by spacer sequences that match previously
encountered foreign DNA. Thus, CRISPR arrays are transcribed
and processed in order to produce mature crRNAs, which are
loaded onto effector protein complexes and function as a guide
to target recognition and degradation.
The CRISPR/Cas system has been engineered to function with
synthetic small guide RNA (sgRNA) in order to perform genome
editing in eukaryotes (Mali et al., 2013) (See Table S2 in Supple-
mentary Material). The sgRNA consists of a 20 nt crRNA sequence
complementary to the target region followed by a 42 nt Cas9-
binding hairpin and a 40 nt transcription terminator. The target
region must be of the form N20NGG that is any 21 nucleotides
followed by GG. NGG is the 3′ protospacer-adjacent motif (PAM)
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and is required for Cas9 binding. This particular PAM sequence is
derived from Streptococcus pyogenes, but other functional PAM
sequences have been characterized from other bacteria (Esvelt
et al., 2013). In addition, if a U6 snRNA or T7 promoters are used
to express the sgRNA, this must start with G or GG, respectively,
in order to maintain transcript initiation. Thus, the target region
must be of the form GN19NGG or GGN18NGG. Ultimately, the
beginning of the sgRNA and the PAM sequence will depend on
the specific promoters and Cas9 used (Figure 1I).
DNA breaks caused by Cas9 are repaired through either homol-
ogous recombination or non-homologous end joining (NHEJ)
mechanisms, thus this system can be used to either disrupt or edit
a gene (i.e., insertions and deletions). Many tools are currently
available online for the design of sgRNAs (Table 1).
Besides genome-editing applications, the CRISPR/Cas9 sys-
tem can be employed for gene expression regulation. The sys-
tem, known as CRISPR interference (CRISPRi), is based on a
catalytically dead Cas9 (dCas9) lacking endonuclease activity co-
expressed with a sgRNA (Gilbert et al., 2013; Qi et al., 2013).
Instead of generating DNA breaks, the recognition complex inter-
feres with transcriptional elongation, RNA polymerase binding, or
transcription factor binding, leading to efficient inhibition of gene
expression. CRISPRi gene silencing is inducible and reversible and
recognition of the targets depends solely on the sgRNA sequence
(Qi et al., 2013).
A “seed” region has been identified as the 12nt region adjacent
to the PAM site. Mismatches in the seed region can dramatically
reduce the repression, while mismatches in the non-seed area can
cause a mild effect. Design guidelines recommend using a length
of 20–25 nt as the base-pairing region of the sgRNA (Larson et al.,
2013) and provide specific design rules based on nucleotide pref-
erence for active sgRNA (Doench et al., 2014). A recent study
aimed at the identification of features of effective sgRNA specific
to CRISPRi, suggests that the target site should be chosen from
−50 to +300 bp relative to the Transcription Start Site (TSS) of a
gene (Gilbert et al., 2014). The authors observed that nucleotide
homopolymers have a strongly negative effect on sgRNA activity
and that the GC content of the sgRNA or the binding site is not
correlated with sgRNA activity, although another study reports a
decreased activity of sgRNA with low or high GC content (Doench
et al., 2014). Moreover, CRISPRi activity seems to be highly sen-
sitive to mismatches between the sgRNA and DNA sequence, thus
the authors conclude that properly designed sgRNA will have mini-
mal off-target effects. However, previous studies reported silencing
activity with sgRNAs exhibiting mismatches to the target in the
seed area (Cradick et al., 2013) and that off-targets might be cell
type dependent and determined by various complicated factors
in addition to primary DNA sequences (Duan et al., 2014). Thus,
side effects still constitute a challenge, which needs to be properly
addressed by further focused research.
Gilbert et al. also introduced the sunCas9 CRISPRa system,
in which expression of a single sgRNA with one binding site
is sufficient to turn on genes that are poorly expressed or that
increase the expression of well-expressed genes (Gilbert et al., 2014;
Tanenbaum et al., 2014).
CRISPRi can also be successfully employed to knock out miR-
NAs, by using a sgRNA/Cas9 complex targeting the pre-miRNA
sequence (Zhao et al., 2014),and to study functional miRNA-target
interactions in vivo by site-specific genome engineering (Bassett
et al., 2014).
Finally, although current tools for CRISPRi are based on the
DNA targeting approach described above, the discovery of other
Cas proteins targeting RNA molecules, such as Cmr, suggests
an alternative post-transcriptional methodology similar to RNAi
(Hale et al., 2009; Zebec et al., 2014).
CONCLUSION
Both RNAi and CRISPRi represent valid approaches for artifi-
cial gene regulation and both can suffer from significant side
effects which may result from factors beyond sequence match.
One clear advantage of CRISPRi over RNAi is that being an exoge-
nous system it does not compete with the endogenous machinery
of miRNA processing. Nevertheless, both techniques require more
work in terms of enhancing targeting efficiency and reducing side
effects.
SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found online
at http://www.frontiersin.org/Journal/10.3389/fbioe.2014.00065/
abstract
REFERENCES
Arroyo, J. D., Gallichotte, E. N., and Tewari, M. (2014). Systematic design and
functional analysis of artificial microRNAs. Nucleic Acids Res. 42, 6064–6077.
doi:10.1093/nar/gku171
Arvey, A., Larsson, E., Sander, C., Leslie, C. S., and Marks, D. S. (2010). Target
mRNA abundance dilutes microRNA and siRNA activity. Mol. Syst. Biol. 6, 1–7.
doi:10.1038/msb.2010.24
Bartel, D. P. (2004). MicroRNAs: genomics, biogenesis, mechanism, and function.
Cell 116, 281–297. doi:10.1016/S0092-8674(04)00045-5
Bartel, D. P. (2009). MicroRNAs: target recognition and regulatory functions. Cell
136, 215–233. doi:10.1016/j.cell.2009.01.002
Bassett, A. R., Azzam, G., Wheatley, L., Tibbit, C., Rajakumar, T., McGowan, S., et al.
(2014). Understanding functional miRNA-target interactions in vivo by site-
specific genome engineering. Nat. Commun. 5, 1–11. doi:10.1038/ncomms5640
Birmingham, A., Anderson, E. M., Reynolds, A., Ilsley-Tyree, D., Leake, D., Fedorov,
Y., et al. (2006). 3’ UTR seed matches, but not overall identity, are associated with
RNAi off-targets. Nat. Meth. 3, 199–204. doi:10.1038/nmeth854
Braasch, D. A., and Corey, D. R. (2001). Locked nucleic acid (LNA): fine-tuning the
recognition of DNA and RNA. Chem. Biol. 8, 1–7. doi:10.1016/S1074-5521(00)
00058-2
Carè, A., Catalucci, D., Felicetti, F., Bonci, D., Addario, A., Gallo, P., et al. (2007).
MicroRNA-133 controls cardiac hypertrophy. Nat. Med. 13, 613–618. doi:10.
1038/nm1582
Chalk, A. M., Wahlestedt, C., and Sonnhammer, E. L. L. (2004). Improved and
automated prediction of effective siRNA. Biochem. Biophys. Res. Commun. 319,
264–274. doi:10.1016/j.bbrc.2004.04.181
Cheng, T. L., Teng, C. F., Tsai, W. H., Yeh, C. W., Wu, M. P., Hsu, H. C., et al.
(2009). Multitarget therapy of malignant cancers by the head-to-tail tandem
array multiple shRNAs expression system. Cancer Gene Ther. 16, 516–531.
doi:10.1038/cgt.2008.102
Chu, C.-Y., and Rana, T. M. (2007). Small RNAs: regulators and guardians of the
genome. J. Cell. Physiol. 213, 412–419. doi:10.1002/jcp.21230
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., et al. (2013). Mul-
tiplex genome engineering using CRISPR/Cas systems. Science 339, 819–823.
doi:10.1126/science.1231143
Cradick, T. J., Fine, E. J., Antico, C. J., and Bao, G. (2013). CRISPR/Cas9 systems
targeting-globin and CCR5 genes have substantial off-target activity. Nucleic
Acids Res. 41, 9584–9592. doi:10.1093/nar/gkt714
Croce, C. M. (2009). Causes and consequences of microRNA dysregulation in can-
cer. Nat. Rev. Genet. 10, 704–714. doi:10.1038/nrg2634
www.frontiersin.org December 2014 | Volume 2 | Article 65 | 5
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Laganà et al. Synthetic RNAs for gene regulation
Cui, W., Ning, J., Naik, U. P., and Duncan, M. K. (2004). OptiRNAi, an RNAi design
tool. Comput. Methods Programs Biomed. 75, 67–73. doi:10.1016/j.cmpb.2003.
09.002
Culler, S. J., Hoff, K. G., and Smolke, C. D. (2010). Reprogramming cellular
behavior with RNA controllers responsive to endogenous proteins. Science 330,
1251–1255. doi:10.1126/science.1192128
Ding, Y., Chan, C. Y., and Lawrence, C. E. (2004). Sfold web server for statistical
folding and rational design of nucleic acids. Nucleic Acids Res. 32, W135–W141.
doi:10.1093/nar/gkh449
Doench, J. G., Hartenian, E., Graham, D. B., Tothova, Z., Hegde, M., Smith, I., et al.
(2014). Rational design of highly active sgRNAs for CRISPR-Cas9-mediated gene
inactivation. Nat. Biotechnol. doi:10.1038/nbt.3026
Dua, P., Yoo, J. W., Kim, S., and Lee, D.-K. (2009). Modified siRNA structure with
a single nucleotide bulge overcomes conventional siRNA-mediated off-target
silencing. Mol. Ther. 19, 1676–1687. doi:10.1038/mt.2011.109
Duan, J., Lu, G., Xie, Z., Lou, M., Luo, J., Guo, L., et al. (2014). Genome-wide identi-
fication of CRISPR/Cas9 off-targets in human genome. Cell Res. 24, 1009–1012.
doi:10.1038/cr.2014.87
Ebert, M. S., Neilson, J. R., and Sharp, P. A. (2007). MicroRNA sponges: com-
petitive inhibitors of small RNAs in mammalian cells. Nat. Meth. 4, 721–726.
doi:10.1038/nmeth1079
Elbashir, S. M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K., and Tuschl, T.
(2001a). Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured
mammalian cells. Nature 411, 494–498. doi:10.1038/35078107
Elbashir, S. M., Martinez, J., Patkaniowska, A., Lendeckel, W., and Tuschl, T. (2001b).
Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila
melanogaster embryo lysate. EMBO J. 20, 6877–6888. doi:10.1093/emboj/20.23.
6877
Esquela-Kerscher, A., and Slack, F. J. (2006). Oncomirs – microRNAs with a role in
cancer. Nat. Rev. Cancer 6, 259–269. doi:10.1038/nrc1840
Esvelt, K. M., Mali, P., Braff, J. L., Moosburner, M., Yaung, S. J., and Church, G. M.
(2013). Orthogonal Cas9 proteins for RNA-guided gene regulation and editing.
Nat. Meth. 10, 1116–1121. doi:10.1038/nmeth.2681
Fire,A.,Xu,S.,Montgomery,M. K.,Kostas,S. A.,Driver,S. E., and Mello,C. C. (1998).
Potent and specific genetic interference by double-stranded RNA in Caenorhab-
ditis elegans. Nature 391, 806–811. doi:10.1038/35888
Franco-Zorrilla, J. M., Valli, A., Todesco, M., Mateos, I., Puga, M. I., Rubio-Somoza,
I., et al. (2007). Target mimicry provides a new mechanism for regulation of
microRNA activity. Nat. Genet. 39, 1033–1037. doi:10.1038/ng2079
Garofalo, M., Condorelli, G., and Croce, C. M. (2008). MicroRNAs in diseases and
drug response. Curr. Opin. Pharmacol. 8, 661–667. doi:10.1016/j.coph.2008.06.
005
Gilbert, L. A., Horlbeck, M. A., Adamson, B., Villalta, J. E., Chen, Y., Whitehead,
E. H., et al. (2014). Genome-scale CRISPR-mediated control of gene repression
and activation. Cell 159, 647–661. doi:10.1016/j.cell.2014.09.029
Gilbert, L. A., Larson, M. H., Morsut, L., Liu, Z., Brar, G. A., Torres, S. E., et al.
(2013). CRISPR-mediated modular RNA-guided regulation of transcription in
eukaryotes. Cell 154, 442–451. doi:10.1016/j.cell.2013.06.044
Guell, M., Yang, L., and Church, G. M. (2014). Genome editing assessment
using CRISPR genome analyzer (CRISPR-GA). Bioinformatics 30, 2968–2970.
doi:10.1093/bioinformatics/btu427
Gunsalus, K. C., and Piano, F. (2005). RNAi as a tool to study cell biology: building
the genome-phenome bridge. Curr. Opin. Cell Biol. 17, 3–8. doi:10.1016/j.ceb.
2004.12.008
Hale, C. R., Zhao, P., Olson, S., Duff, M. O., Graveley, B. R., Wells, L., et al. (2009).
RNA-guided RNA cleavage by a CRISPR RNA-Cas protein complex. Cell 139,
945–956. doi:10.1016/j.cell.2009.07.040
Haraguchi, T., Nakano, H., Tagawa, T., Ohki, T., Ueno, Y., Yoshida, T., et al.
(2012). A potent 2′-O-methylated RNA-based microRNA inhibitor with
unique secondary structures. Nucleic Acids Res. 40, e58–e58. doi:10.1093/nar/
gkr1317
Haraguchi, T., Ozaki, Y., and Iba, H. (2009). Vectors expressing efficient RNA decoys
achieve the long-term suppression of specific microRNA activity in mammalian
cells. Nucleic Acids Res. 37, e43–e43. doi:10.1093/nar/gkp040
Heigwer, F., Kerr, G., and Boutros, M. (2014). Correspondence. Nat. Meth. 11,
122–123. doi:10.1038/nmeth.2812
Helwak, A., Kudla, G., Dudnakova, T., and Tollervey, D. (2013). Mapping the human
miRNA interactome by CLASH reveals frequent noncanonical binding. Cell 153,
654–665. doi:10.1016/j.cell.2013.03.043
Hsieh, A., Bo, R., Manola, J., Vazquez, F., Bare, O., Khvorova, A., et al. (2004). A
library of siRNA duplexes targeting the phosphoinositide 3-kinase pathway:
determinants of gene silencing for use in cell-based screens. Nucleic. Acids Res.
32, 893–901. doi:10.1093/nar/gkh238
Hsu, P. D., Scott, D. A., Weinstein, J. A., Ran, F. A., Konermann, S., Agarwala, V., et al.
(2013). DNA targeting specificity of RNA-guided Cas9 nucleases. Nat. Biotech-
nol. 31, 827–832. doi:10.1038/nbt.2647
Hwang, W. Y., Fu, Y., Reyon, D., Maeder, M. L., Tsai, S. Q., Sander, J. D., et al. (2013).
Brief communications. Nat. Biotechnol. 31, 227–229. doi:10.1038/nbt.2501
Ichihara, M., Murakumo, Y., Masuda, A., Matsuura, T., Asai, N., Jijiwa, M., et al.
(2007). Thermodynamic instability of siRNA duplex is a prerequisite for
dependable prediction of siRNA activities. Nucleic Acids Res. 35, e123–e123.
doi:10.1093/nar/gkm699
Jackson, A. L., Burchard, J., Schelter, J., Chau, B. N., Cleary, M., Lim, L., et al.
(2006). Widespread siRNA “off-target” transcript silencing mediated by seed
region sequence complementarity. RNA 12, 1179–1187. doi:10.1261/rna.25706
Jiang, P., Wu, H., Da, Y., Sang, F., Wei, J., Sun, X., et al. (2007). RFRCDB-
siRNA: Improved design of siRNAs by random forest regression model cou-
pled with database searching. Comput. Methods Programs Biomed. 87, 230–238.
doi:10.1016/j.cmpb.2007.06.001
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., and Charpentier,
E. (2012). A programmable dual-RNA-guided DNA endonuclease in adaptive
bacterial immunity. Science 337, 816–821. doi:10.1126/science.1225829
Katoh, T., and Suzuki, T. (2007). Specific residues at every third position of siRNA
shape its efficient RNAi activity. Nucleic Acids Res. 35, e27–e27. doi:10.1093/nar/
gkl1120
Khvorova, A., Reynolds, A., and Jayasena, S. D. (2003). Functional siRNAs and miR-
NAs exhibit strand bias. Cell 115, 209–216. doi:10.1016/S0092-8674(03)00801-8
Kim, D. H., and Rossi, J. J. (2007). Strategies for silencing human disease using RNA
interference. Nat. Rev. Genet. 8, 173–184. doi:10.1038/nrg2006
Kluiver, J., Gibcus, J. H., Hettinga, C., Adema, A., Richter, M. K. S., Halsema, N.,
et al. (2012). Rapid generation of MicroRNA sponges for microRNA inhibition.
PLoS ONE 7:e29275. doi:10.1371/journal.pone.0029275
Krützfeldt, J., Rajewsky, N., Braich, R., Rajeev, K. G., Tuschl, T., Manoharan, M., et al.
(2005). Silencing of microRNAs in vivo with “antagomirs”. Nature 438, 685–689.
doi:10.1038/nature04303
Lagana, A., Acunzo, M., Romano, G., Pulvirenti, A., Veneziano, D., Cascione, L.,
et al. (2014). miR-Synth: a computational resource for the design of multi-site
multi-target synthetic miRNAs. Nucleic Acids Res. 42, 5416–5425. doi:10.1093/
nar/gku202
Larson, M. H., Gilbert, L. A., Wang, X., Lim, W. A., Weissman, J. S., and Qi, L. S.
(2013). CRISPR interference (CRISPRi) for sequence-specific control of gene
expression. Nat. Protoc. 8, 2180–2196. doi:10.1038/nprot.2013.132
Larsson, E., Sander, C., and Marks, D. (2010). mRNA turnover rate limits siRNA
and microRNA efficacy. Mol. Syst. Biol. 6, 1–9. doi:10.1038/msb.2010.89
Li, X., Yoo, J. W., Lee, J. H., Hahn, Y., Kim, S., and Lee, D.-K. (2010). Identification of
sequence features that predict competition potency of siRNAs. Biochem. Biophys.
Res. Commun. 398, 92–97. doi:10.1016/j.bbrc.2010.06.041
Liang, J. C., Bloom, R. J., and Smolke, C. D. (2011). Engineering biological systems
with synthetic RNA molecules. Mol. Cell 43, 915–926. doi:10.1016/j.molcel.2011.
08.023
Liu, Q., Zhou, H., Cui, J., Cao, Z., and Xu, Y. (2012a). Reconsideration of in-silico
siRNA design based on feature selection: a cross-platform data integration per-
spective. PLoS ONE 7:e37879. doi:10.1371/journal.pone.0037879
Liu, Q., Zhou, H., Zhu, R., Xu, Y., and Cao, Z. (2012b). Reconsideration of in silico
siRNA design from a perspective of heterogeneous data integration: problems
and solutions. Brief Bioinform 15, 292–305. doi:10.1093/bib/bbs073
Lu, Z. J., and Mathews, D. H. (2008). OligoWalk: an online siRNA design tool
utilizing hybridization thermodynamics. Nucleic Acids Res. 36, W104–W108.
doi:10.1093/nar/gkn250
Ma, H., Zhang, J., and Wu, H. (2014). Designing Ago2-specific siRNA/shRNA to
avoid competition with endogenous miRNAs. Mol Ther Nucleic Acids 3, e176.
doi:10.1038/mtna.2014.27
Ma, M., Ye, A. Y., Zheng, W., and Kong, L. (2013). A guide RNA sequence design
platform for the CRISPR/Cas9 system for model organism genomes. Biomed Res.
Int. 2013, 1–4. doi:10.1155/2013/270805
Malefyt, A. P., Wu, M., Vocelle, D. B., Kappes, S. J., Lindeman, S. D., Chan, C., et al.
(2014). Improved asymmetry prediction for short interfering RNAs. FEBS J. 281,
320–330. doi:10.1111/febs.12599
Frontiers in Bioengineering and Biotechnology | Bioinformatics and Computational Biology December 2014 | Volume 2 | Article 65 | 6
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Laganà et al. Synthetic RNAs for gene regulation
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., et al. (2013).
RNA-guided human genome engineering via Cas9. Science 339, 823–826.
doi:10.1126/science.1232033
Martin, H. C., Wani, S., Steptoe, A. L., Krishnan, K., Nones, K., Nourbakhsh, E.,
et al. (2014). Imperfect centered miRNA binding sites are common and can
mediate repression of target mRNAs. Genome Biol. 15, R51. doi:10.1186/gb-
2014-15-3-r51
Matveeva, O., Nechipurenko, Y., Rossi, L., Moore, B., Saetrom, P., Ogurtsov, A.
Y., et al. (2007). Comparison of approaches for rational siRNA design lead-
ing to a new efficient and transparent method. Nucleic Acids Res. 35, e63–e63.
doi:10.1093/nar/gkm088
Montague, T. G., Cruz, J. M., Gagnon, J. A., Church, G. M., and Valen, E. (2014).
CHOPCHOP: a CRISPR/Cas9 and TALEN web tool for genome editing. Nucleic
Acids Res. 42, W401–W407. doi:10.1093/nar/gku410
Naito, Y., Ui-Tei, K., Nishikawa, T., Takebe, Y., and Saigo, K. (2006). siVirus: web-
based antiviral siRNA design software for highly divergent viral sequences.
Nucleic Acids Res. 34, W448–W450. doi:10.1093/nar/gkl214
Naito, Y., Yoshimura, J., Morishita, S., and Ui-Tei, K. (2009). siDirect 2.0: updated
software for designing functional siRNA with reduced seed-dependent off-target
effect. BMC Bioinformatics 10:392. doi:10.1186/1471-2105-10-392
Obad, S., Santos dos, C. O., Petri, A., Heidenblad, M., Broom, O., Ruse, C., et al.
(2011). Silencing of microRNA families by seed-targeting tiny LNAs. Nat. Genet.
43, 371–378. doi:10.1038/ng.786
Petersen, M., and Wengel, J. (2003). LNA: a versatile tool for therapeutics and
genomics. Trends Biotechnol. 21, 74–81. doi:10.1016/S0167-7799(02)00038-0
Qi, L. S., Larson, M. H., Gilbert, L. A., Doudna, J. A.,Weissman, J. S.,Arkin,A. P., et al.
(2013). Repurposing CRISPR as an RNA-guided platform for sequence-specific
control of gene expression. Cell 152, 1173–1183. doi:10.1016/j.cell.2013.02.022
Ran, F. A., Hsu, P. D., Lin, C.-Y., Gootenberg, J. S., Konermann, S., Trevino, A. E.,
et al. (2013). Double nicking by RNA-guided CRISPR Cas9 for enhanced genome
editing specificity. Cell 154, 1380–1389. doi:10.1016/j.cell.2013.08.021
Reynolds, A., Leake, D., Boese, Q., Scaringe, S., Marshall, W. S., and Khvorova,
A. (2004). Rational siRNA design for RNA interference. Nat. Biotechnol. 22,
326–330. doi:10.1038/nbt936
Sayed, D., Rane, S., Lypowy, J., He, M., Chen, I.-Y., Vashistha, H., et al. (2008).
MicroRNA-21 targets Sprouty2 and promotes cellular outgrowths. Mol. Biol.
Cell 19, 3272–3282. doi:10.1091/mbc.E08-02-0159
Schramm, G., and Ramey, R. (2005). siRNA design including secondary structure
target site prediction. Nat. Meth. 2. doi:10.1038/nmeth780
Shabalina, S. A., Spiridonov, A. N., and Ogurtsov, A. Y. (2006). Computational mod-
els with thermodynamic and composition features improve siRNA design. BMC
Bioinformatics 7:65. doi:10.1186/1471-2105-7-65
Sharma, V., Nomura, Y., and Yokobayashi, Y. (2008). Engineering complex
Riboswitch regulation by dual genetic selection. J. Am. Chem. Soc. 130,
16310–16315. doi:10.1021/ja805203w
Shin, C., Nam, J.-W., Farh, K. K.-H., Chiang, H. R., Shkumatava, A., and Bartel, D. P.
(2010). Expanding the microRNA targeting code: functional sites with centered
pairing. Mol. Cell 38, 789–802. doi:10.1016/j.molcel.2010.06.005
Straka, M., and Boese, Q. (2010). Current topics in RNAi: why rational pooling of
siRNAs is SMART. Thermo Fisher Scientific Inc
Strapps, W. R., Pickering, V., Muiru, G. T., Rice, J., Orsborn, S., Polisky, B. A.,
et al. (2010). The siRNA sequence and guide strand overhangs are deter-
minants of in vivo duration of silencing. Nucleic Acids Res. 38, 4788–4797.
doi:10.1093/nar/gkq206
Summerton, J., and Weller, D. (1997). Morpholino antisense oligomers: design,
preparation, and properties. Antisense Nucleic Acid Drug Dev. 7, 187–195.
doi:10.1089/oli.1.1997.7.187
Tafer, H., Ameres, S. L., Obernosterer, G., Gebeshuber, C. A., Schroeder, R., Martinez,
J., et al. (2008). The impact of target site accessibility on the design of effective
siRNAs. Nat. Biotechnol. 26, 578–583. doi:10.1038/nbt1404
Tanenbaum, M. E., Gilbert, L. A., Qi, L. S., Weissman, J. S., and Vale, R. D. (2014). A
protein-tagging system for signal amplification in gene expression and fluores-
cence imaging. Cell 159, 635–646. doi:10.1016/j.cell.2014.09.039
Thomas, M., Lieberman, J., and Lal, A. (2010). Desperately seeking microRNA tar-
gets. Nat. Struct. Mol. Biol. 17, 1169–1174. doi:10.1038/nsmb.1921
Ui-Tei, K., Naito, Y., Takahashi, F., Haraguchi, T., Ohki-Hamazaki, H., Juni, A.,
et al. (2004). Guidelines for the selection of highly effective siRNA sequences
for mammalian and chick RNA interference. Nucleic Acids Res. 32, 936–948.
doi:10.1093/nar/gkh247
Upadhyay, S. K., and Sharma, S. (2014). SSFinder: high throughput CRISPR-Cas
target sites prediction tool. Biomed Res. Int. 2014, 1–4. doi:10.1155/2014/742482
Vert, J. P., Foveau, N., Lajaunie, C., and Vandenbrouck, Y. (2006). An accurate and
interpretable model for siRNA efficacy prediction. BMC Bioinformatics 7:520.
doi:10.1186/1471-2105-7-520
Xiao, A., Cheng, Z., Kong, L., Zhu, Z., Lin, S., Gao, G., et al. (2014). CasOT: a
genome-wide Cas9/gRNA off-target searching tool. Bioinformatics 30, 1180–
1182. doi:10.1093/bioinformatics/btt764
Xie, S., Shen, B., Zhang, C., Huang, X., and Zhang, Y. (2014). sgRNAcas9: a soft-
ware package for designing CRISPR sgRNA and evaluating potential off-target
cleavage sites. PLoS ONE 9:e100448. doi:10.1371/journal.pone.0100448
Xu, P., Zhang, Y., Kang, L., Roossinck, M. J., and Mysore, K. S. (2006). Compu-
tational estimation and experimental verification of off-target silencing dur-
ing posttranscriptional gene silencing in plants. Plant Physiol. 142, 429–440.
doi:10.1104/pp.106.083295
Yoo, J. W., Kim, S., and Lee, D.-K. (2008). Competition potency of siRNA is specified
by the 5’-half sequence of the guide strand. Biochem. Biophys. Res. Commun. 367,
78–83. doi:10.1016/j.bbrc.2007.12.099
Zebec, Z., Manica, A., Zhang, J., White, M. F., and Schleper, C. (2014). CRISPR-
mediated targeted mRNA degradation in the Archaeon Sulfolobus solfataricus.
Nucleic Acids Res. 42, 5280–5288. doi:10.1093/nar/gku161
Zhao, Y., Dai, Z., Liang, Y., Yin, M., Ma, K., He, M., et al. (2014). Sequence-
specific inhibition of microRNA via CRISPR/CRISPRi system. Sci. Rep. 4:3943.
doi:10.1038/srep03943
Zhu, L. J., Holmes, B. R., Aronin, N., and Brodsky, M. H. (2014). CRISPRseek:
a bioconductor package to identify target-specific guide RNAs for CRISPR-
Cas9 genome-editing systems. PLoS ONE 9:e108424. doi:10.1371/journal.pone.
0108424
Ziegler, S., Eberle, M. E., Wölfle, S. J., Heeg, K., and Bekeredjian-Ding, I. (2013).
Bifunctional oligodeoxynucleotide/antagomir constructs: evaluation of a new
tool for microRNA silencing. Nucleic Acid Therapeut. 23, 427–434. doi:10.1089/
nat.2013.0447
Conflict of Interest Statement: The authors declare that the research was conducted
in the absence of any commercial or financial relationships that could be construed
as a potential conflict of interest.
Received: 30 September 2014; accepted: 23 November 2014; published online: 11
December 2014.
Citation: Laganà A, Shasha D and Croce CM (2014) Synthetic RNAs for gene regu-
lation: design principles and computational tools. Front. Bioeng. Biotechnol. 2:65. doi:
10.3389/fbioe.2014.00065
This article was submitted to Bioinformatics and Computational Biology, a section of
the journal Frontiers in Bioengineering and Biotechnology.
Copyright © 2014 Laganà, Shasha and Croce. This is an open-access article distributed
under the terms of the Creative Commons Attribution License (CC BY). The use, dis-
tribution or reproduction in other forums is permitted, provided the original author(s)
or licensor are credited and that the original publication in this journal is cited, in
accordance with accepted academic practice. No use, distribution or reproduction is
permitted which does not comply with these terms.
www.frontiersin.org December 2014 | Volume 2 | Article 65 | 7
